6-Bromo-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one, 95.0%, 1g

5-TAMRA SE>90.0%(HPLC)5mg

Trimethoxy(7-octen-1-yl)silane>90.0%(GC)5mL

3-Bromo-n-(2,2,2-trifluoroethyl)aniline, 95%, 250mg

4-(5-Bromo-1H-indol-3-yl)pyrimidin-2-amine, 97%, 100mg

4-Ethynyltriphenylamine>98.0%(HPLC)(N)1g

2-BROMO-7-METHYL-5H-PYRROLO[2,3-B]PYRAZINE, 95.0%, 1g

1-METHYL-4-(4-METHYLHEPTA-1,6-DIEN-4-YL)BENZENE, 95.0%, 2g

Par de oculares, tubo de Ø 23,2 mm

2,6-Dichloro-4-(piperidin-1-ylcarbonyl)pyridine, 95.0%, 1g

Conexión de junta esférica, 40, 120 mm, 1 pieza

ETHYL 2-ACETOXY-2-(DIETHOXYPHOSPHORYL)ACETATE, 95.0%, 100mg

4-Amino-N-ethyl-benzenesulfonamide, 95.0%, 1g